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People with dementia are frequently admitted to an acute hospital.
In the UK, at any given time, around 6% of people with dementia
are in-patients in general hospitals, compared with approximately
0.6% of over-65s without dementia.1 People with dementia are
admitted to hospital two to three times more often than people
of the same age without dementia.2 In the USA, admissions to
hospital for people over the age of 85 years with dementia
increased from 700 000 in 2000 to 1.2 million in 2008. Dementia
is particularly common in patients in acute medical wards, with
prevalences in this setting ranging between 40 and 43% in the
UK, Italy and Switzerland.3–5 Studies from a range of countries
have demonstrated how people with dementia in an acute
hospital are at increased risk of mortality and adverse events,
functional decline during their stay, higher risk of being
discharged into care homes and longer length of stay.6 In the
UK, there have been increasing concerns about the care that frail
older people receive when they are admitted to acute hospitals.7
The term ‘behavioural and psychological symptoms of
dementia’ (BPSD) encompasses a range of symptoms including
agitation, aggression, delusions, hallucinations, depression and
apathy. These symptoms are common, multifactorial in origin
and probably secondary to complex interactions between the
severity of dementia, the environment and other illness. They
are distressing for people with dementia and those who care for
them. Family caregivers have given rich reports about how BPSD
may worsen during hospital admission and how acute hospital
staff struggle to adequately manage these,8 however, we have little
information on how common behavioural and psychiatric
symptoms are in this setting. This is essential if we are to develop
and evaluate management strategies for BPSD in the acute
hospital, in particular effective non-pharmacological interventions,
and to better justify the necessity of liaison psychiatry services
within this setting. Our principal aim in this study was to examine
the prevalence of BPSD in older people with unplanned medical
admission to hospital. Our specific objectives were to (a) describe
the prevalence and subtypes of BPSD in this population, and
(b) examine the patient characteristics associated with BPSD. Our
secondary aim was to explore associations between BPSD
(including subtypes) and quality of care, length of stay, adverse events,
discharge destination, mortality and costs of the hospital admission.
Method
Setting
For this longitudinal cohort study we recruited from two acute
hospitals in London, UK. Both cover a large area encompassing
socioeconomic and ethnic diversity, serving a population of
two million people from six primary care trusts (healthcare
commissioning bodies) and four mental health trusts. The
hospitals have differing strengths and weaknesses in terms of their
Care Quality Commission ratings and are at different stages of
implementing the English National Dementia Strategy with
varying provision of liaison psychiatry. This study was approved
by the Central London research Ethics Committee 3, reference
10/H0716/79.
Participants
In both hospitals, all patients are admitted via accident and
emergency services to the medical acute admissions unit before
transfer to elderly care or medical wards (total of 20 wards).
Two research assistants spent 5 months at each site, assessing
within 72 h of admission all patients admitted to each unit under
the care of the geriatricians (recruitment period 4 April 2011 to
6 March 2012). Clinical staff identified patients who met the
following inclusion criteria: (a) aged 70 years or above with an
unplanned acute medical admission; (b) able to give written
informed consent or with an informal carer or ‘professional
consultee’ available to give assent; (c) sufficient English language
to complete the study ratings; (d) Abbreviated Mental Test Score
(AMTS)9 of 47/10 (routinely measured on admission).
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Background
Dementia is common in older people admitted to acute
hospitals. There are concerns about the quality of care they
receive. Behavioural and psychiatric symptoms of dementia
(BPSD) seem to be particularly challenging for hospital staff.
Aims
To define the prevalence of BPSD and explore their clinical
associations.
Method
Longitudinal cohort study of 230 people with dementia, aged
over 70, admitted to hospital for acute medical illness, and
assessed for BPSD at admission and every 4 (+1) days until
discharge. Other measures included length of stay, care
quality indicators, adverse events and mortality.
Results
Participants were very impaired; 46% at Functional
Assessment Staging Scale (FAST) stage 6d or above
(doubly incontinent), 75% had BPSD, and 43% had some
BPSD that were moderately/severely troubling to staff. Most
common were aggression (57%), activity disturbance (44%),
sleep disturbance (42%) and anxiety (35%).
Conclusions
We found that BPSD are very common in older people
admitted to an acute hospital. Patients and staff would
benefit from more specialist psychiatric support.
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We excluded patients who indicated verbally or non-verbally
that they did not wish to participate, those who were moribund,
non-English speaking or where there were clinical concerns
regarding them being approached.
Screening
All potential participants were screened for delirium using the
Confusion Assessment Method (CAM).10 This has a sensitivity
of over 94% and a specificity over 90% for detecting delirium
and distinguishes accurately between delirium and dementia.10
Those who were not delirious and consented to the study were
assessed using the Mini-Mental State Examination (MMSE).11 If
their score was 424 they were entered into the study. Patients
with delirium were screened again 48 h later, if this had resolved
they underwent testing with the MMSE. If they remained
persistently delirious they were not eligible to participate as we
could not establish whether or not they had an underlying
dementia. However, patients with delirium who had a previous
diagnosis of dementia from a specialist service (neurology,
geriatrics, old age psychiatry) documented in their hospital notes
were eligible.
Baseline study measures
Dementia diagnosis was confirmed using a structured clinical
assessment based on operationalised DSM-IV criteria.12 This
comprised cognitive testing from the MMSE, structured review
of the clinical notes and discussion with family and other carers.
We only diagnosed new cases of dementia in the absence of
delirium. Research staff did not give the diagnosis of dementia
to the participant or their families. This was documented in their
notes so the clinical team could manage this as per their usual
procedures. Dementia severity was measured using the Functional
Assessment Staging Scale (FAST).13 Reason for admission,
comorbidities (Charlson Score)14 and demographics were
obtained from medical notes.
Assessment for BPSD
Participants were assessed for BPSD at baseline (during the first
72 h of admission) using the Behavioural Pathology in Alzheimer’s
Disease (Behave-AD),15 a scale designed for prospective studies of
behavioural symptoms in dementia. In addition we included
information from discussions with family carers and ward staff
and all available hospital notes. The scale covers seven domains
of BPSD: paranoid and delusional ideation, hallucinations,
activity disturbances, aggressiveness, diurnal rhythm disturbance,
affective disturbance, anxieties and phobias. Scores can be
generated for the presence or absence (0/1) or severity of
symptoms (0, none; 1, mild; 2, moderate; 3, severe), giving a
maximum score of 75. The scale also includes a global rating of
how troubling the BPSD are to family carers or staff (0, not
troubling; 1, mildly troubling or dangerous; 2, moderately
troubling or dangerous; 3, severely troubling or intolerable).
Subsequent assessments
Patients were reviewed every 4 (+1) days with the Behave-AD,
until discharge or they were deemed medically fit and ‘awaiting
placement’ in a care home. Hospital notes were examined and
discussions held with clinical staff to identify any BPSD that
had occurred in the 4 (+1) days since the previous assessment.
Interrater reliability for the Behave-AD was checked for 35 random
participants. Agreement ranged from 84.9 to 97.1% (kappa
(k) = 0.60–0.75). It was possible that BPSD may have occurred
secondary to incident delirium. To perform a sensitivity analysis
for this we undertook regular delirium assessments using the
CAM every 4 (+1) days at the same time as the BPSD
assessment at the second hospital site (n=113).
Other clinical measures
Data on length of admission, mortality and change of residence on
discharge from hospital (from own home to a care home) were
collected from hospital notes.
Adverse events
These were recorded using validated pre-set criteria, defined as ‘an
unintended injury caused by medical management rather than by
the disease process and which is sufficiently serious to lead to
prolongation of hospitalisation or to temporary or permanent
impairment or disability to the patient at time of discharge’; these
included falls.16
Quality of care
Weused the ACOVE (AssessingCare of Vulnerable Elders) indicators:
standardised quality indicators in general hospital care and ‘geriatric-
prevalent’ conditions (for example dementia and delirium).17 They
are a set of IF/THEN statements for 17 conditions, for example,
‘IF patient has an indwelling catheter placed either on admission
or during hospitalization THEN there should be documented
indication of need for catheter’. We used a standard method to
calculate percentage adherence for each study participant.17
Sample size
We assumed a point prevalence of BPSD of 31% from a
community-based sample of people with dementia.18 We aimed
to recruit 250 patients (125 from each hospital) to ensure a
95% confidence interval for prevalence estimates of BPSD with
an acceptable 6% precision.
Data analysis
We used simple descriptive statistics for the demographic features
of the cohort. We calculated the prevalence (and 95% confidence
intervals) of BPSD of any severity at the baseline assessment and
then cumulatively at any time during the admission. We calculated
the prevalence of individual types of BPSD (and 95% confidence
intervals) as described in the seven domains of the Behave-AD
scale. The continuous variable length of admission and ACOVE
scores were dichotomised by cutting at the median score. We
examined associations between participant characteristics, other
clinical measures and the presence of BPSD using Fisher’s exact test
and with the severity of BPSD using analysis of variance (ANOVA).
We also explored the association between BPSD severity
(mean Behave-AD score over admission) and quality of care
(ACOVE score), adverse events, length of stay, mortality during
admission and discharge to institutional care (for those living in
their own home before admission). The association was modelled
using linear or logistic regression, with Behave-AD mean score
(for each BPSD type and total) as independent variable. Thus,
for continuous measures this gives the mean difference for a
one-point increase in the Behave-AD. For binary measures
(adverse events, mortality and change of residence to a care home)
we calculated the odds ratio of the outcome for a one-point
increase in the Behave-AD. Length of stay had a skewed distribution
and was log-transformed for this analysis.
Sensitivity analysis for the impact of delirium
To examine whether BPSD prevalence estimates were altered by
participants developing delirium, we conducted a sensitivity
analysis, recalculating the prevalence of BPSD for participants at
190
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hospital site 2, excluding those who had delirium at any assessment
during their admission.
Economic data
Data of sufficient quality were available from one hospital site on
98 consecutive patients enrolled into the study prior to 31 December
2011. These included charges accruing to the hospital for each
participant’s admission: staff contact time, prescription medication
use, hospital overheads and other running costs. We compared
the cost of admission for patients who had any BPSD at baseline
against costs for patients with no BPSD at baseline using a non-
parametric Mann–Whitney test. Costs are reported as 2011–2012
values. As is common with healthcare data, costs were highly
skewed (skewness, 2.88) because a small number of patients
consumed a disproportionately large level of resources. As a result,
the assumptions required for standard statistical approaches based
on normally distributed data do not hold. Therefore a Bayesian
parametric approach to analysis of costs was followed. The
relationship between cost and mean BPSD score was estimated,
taking into account the skewness, by using linear regression and
non-parametric bootstrapping with 5000 resamples and reporting
bias-corrected and accelerated 95% confidence intervals.19
Ethical issues
Our participants were acutely ill, had dementia, delirium or
both and were not able to give informed consent. Our consent
procedure complied with capacity legislation governing England
and Wales while balancing the need to recruit a representative
cohort of people with dementia (Mental Capacity Act 2005). If a
patient agreed to participate, we conducted a structured assessment
of their capacity to consent. If they had capacity, written informed
consent was obtained. If they did not have capacity, we attempted
to identify their next of kin, carer or another close person to give
proxy assent. This could be given verbally over the telephone and
we sent this personal consultee the assent form in the post to sign
and return. If these forms were not returned, the participant’s data
were withdrawn and destroyed at the end of the study. If we could
not contact a next of kin within 48 h of initial screening we
approached a professional consultee for assent (a senior member
of the clinical care team who was not directly involved in the
research or the patient’s care).20 The researchers had regular
clinical supervision and a protocol to follow if they witnessed
suboptimal care or distressing incidents.
Results
Recruitment
A total of 1612 people were screened (Fig. 1). Of these, 292 met
inclusion criteria. The most common reasons for exclusion were
that the MMSE score was 424 or AMTS score 47 (n= 634) or
patients were discharged before they could be assessed (n= 145).
Of the 292 recruited to the study, a further 62 were excluded
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Total
(n=1612)
Screened, met study criteria
(n=292)
Personal consultee
(n=216)
Total participating
personal consultee
(n=189)
Patient
had capacity
(n=63)
Total participating
with capacity
(n=29)
Consented,
not eligible
(n=34)
Assented,
not eligible
(n=4)
Assent form
not returned
(n=23)
Patient did not
have capacity
(n=229)
Professional consultee
(n=13)
Total participating
professional consultee
(n=12)
Screened, did not meet criteria
(ineligible)
(n=1320)
MMSE 424/AMTS 47 n=634
Discharged before seen n=145
Does not consent n=58
Too ill to take part n=60
Missed the 72 h window n=78
Not care of the elderly n=95
Limited English n=124
Does not fit DSM criteria n=103
Persistent delirium n=8
Planned admission n=5
Deceased n=10
Not
suitable
(n=1)
Fig. 1 Study flow chart.
MMSE, Mini-Mental Sate Examination, AMTS, Abbreviated Mental Test Score.
Sampson et al
because they did not fulfil study inclusion criteria at baseline
assessment or because family carers who gave telephone assent
did not post back signed assent forms. There were 230 participants
in the cohort (117 from hospital 1 and 113 from hospital 2).
Median length of admission was 12 days (range, 2–72; inter-
quartile range (IQR), 7–23 and median number of study
assessments per participant was 3 (range, 1–20; IQR, 2–5. No
participants dropped out during the study.
Study participants
There were no significant differences between the characteristics of
participants from hospital sites 1 and 2 with respect to gender,
proportion of those with a prior diagnosis of dementia, usual place
of residence or comorbidity on the Charlson score. Participants
from hospital 1 were significantly older (t=72.26, P=0.025)
and more were of white British origin, 82% compared with 69%
at hospital 2 (w2 = 25.9, P= 0.004). Few participants had missing
data: three (1.3%) had data missing on the CAM at baseline,
and four (1.7%) sets of notes were not available for review
post-discharge.
Participants were predominantly female (66%), with a mean
age 87.2 years (s.d. = 5.9) and of white British ethnicity (76%)
(Table 1). A known diagnosis of dementia prior to the hospital
admission was present in 70% (Table 2). Most were admitted from
their own home and 63% had moderate to severe functional
impairment as a result of their dementia. During their stay, 13%
died. Of those who survived and were admitted from their own
home, 23.4% were subsequently discharged into a care home.
The most common coded causes of admission were pneumonia/
chest infection (26.7%), urinary tract infection (15.7%), fall or
fracture (11.3%) and cardiac events (9.6%). At the initial study as-
sessment (within 72 h of admission), 11.4% had delirium.
Behavioural and psychiatric symptoms of dementia
At the first study assessment, 62% (95% CI 55–68) had BPSD. The
most common symptoms at baseline were aggression 43% (95%
CI 37–49) and activity disturbance 25% (95%CI 20–31). Considering
the whole admission 75% (95% CI 69–80) of participants had
BPSD at some point, with 57% having aggression (95% CI 50–63)
and 44% activity disturbance (95% CI 37–51) (Table 3). The least
common BPSD were paranoia and hallucinations. In total, 47% of
the cohort experienced three or more BPSD symptoms during
their admission. At the first assessment, 29% of participants
had experienced BPSD that were moderately or severely troubling
to staff or other carers, this increased to 43% for the whole
admission.
Sensitivity analyses for the impact of delirium
Recalculating the prevalence of BPSD in participants from
hospital site 2, excluding those with delirium at any study
assessment point had a small effect, decreasing the prevalence
estimates for hallucinations (from 14.8 to 10.1%), activity
disturbance (from 43.9 to 36.4%), sleep disturbance (from 42.2
to 35.4%), affective disturbance (from 33.0 to 28.3%) and overall
prevalence of BPSD of any type (from 75.0 to 68.7% (see online
Table DS1)).
Associations with behavioural and psychiatric
symptoms of dementia
Associations between patient characteristics and BPSD are
reported in Tables 1 and 2. We found that BPSD were more
common in men, those admitted from residential or nursing
homes, those with a prior diagnosis of dementia and the presence
of delirium on admission. Adverse events and mortality were also
associated with the total severity of BPSD. Exploring this further
in regression analyses (Table 4) suggested a possible association
between paranoia and activity disturbance and adverse events.
Our analysis did not indicate an association between the length
of admission and mean severity of BPSD during the hospital stay.
Costs
For 98 patients from hospital 2 with complete cost data, the mean
cost of admission per patient was £14 464 (s.d. = 15 795) and
median cost per patient £9923 (IQR £5195–15 960). The mean
total cost of admission for participants without BPSD at baseline
was £12 150 (observed sample skewness, 0.69) and the median cost
£10 094 (IQR £4491–£16 821). For those with BPSD the mean cost
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Table 1 Cohort demographics and associations with behavioural and psychiatric symptoms of dementia (BPSD) for 230 older people
in the acute hospital
Total cohort, n (%)
Assessment for BPSD,a % (n=230) BPSD severity,b Behave-AD scale
Demographics (n=230) Absent (n=58) Present (n=172) P Mean (s.d.) P
Gender
Female 151 (65.7) 29.1 70.9 2.8 (3.7)
Male 79 (34.3) 17.7 82.3 0.078 3.7 (3.7) 0.075
Age, years
75–84 85 (37.0) 32.8 38.4 3.0 (3.6)
85–94 118 (51.3) 50.0 51.7 3.4 (4.0)
95+ 27 (11.7) 17.2 9.9 0.295 2.4 (3.2) 0.448
Ethnicity
White British 175 (76.1) 26.3 73.7 2.9 (3.7)
Black Caribbean 15 (6.5) 20.0 80.0 2.9 (2.9)
Other 40 (17.4) 22.5 77.5 0.823 4.2 (4.1) 0.141
Place of residencec
Home 147 (67.1) 26.5 73.5 2.6 (3.5)
Residential home 26 (11.9) 15.4 84.6 4.4 (3.9)
Nursing home 41 (18.7) 29.3 70.7 3.5 (3.7)
Other 5 (2.3) 20.0 80.0 0.614 6.8 (8.3) 0.014
a. At any assessment during hospital admission.
b. Mean score over admission.
c. Data available for n=219 only.
Behavioural and psychiatric symptoms in people with dementia admitted to hospital
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Table 2 Cohort clinical characteristics and associations with behavioural and psychiatric symptoms of dementia (BPSD) for
230 older people in the acute hospital
Assessment for BPSD,a % (n=230) BPSD severity,b Behave-AD scale
Total cohort, n (%)
(n=230)
Absent
(n=58)
Present
(n=172) P Mean (s.d.) P
Functional Assessment Staging Scale score
3–5 (objective functional deficit, difficulties with activities
of daily living) 86 (37.4) 31.4 68.6 2.4 (3.5)
6a–6c (help required putting on clothes, toileting
or bathing) 39 (17.0) 17.9 82.1 3.6 (4.2)
6d–6e (urinary and faecal incontinence) 74 (32.2) 21.6 78.4 3.4 (3.5)
7a–f (less than 6 words, can no longer walk, sit up,
smile, hold up head) 31 (13.5) 25.8 74.2 0.358 3.7 (4.3) 0.153
Known diagnosis of dementia prior to index admission
Yes 161 (70.0) 21.1 78.9 3.7 (4.1)
No 69 (30.0) 34.8 65.2 0.032 1.6 (2.1) 50.001
Delirium on admission (Confusion Assessment Method)c
Yes 26 (11.4) 7.7 92.3 5.3 (4.6)
No 201 (88.6) 27.4 72.6 0.030 2.8 (3.6) 0.001
Charlson comorbidity score
0–1 57 (24.8) 22.8 77.2 2.5 (3.4)
2–3 124 (53.9) 27.4 72.6 3.2 (3.9)
4+ 49 (21.3) 22.5 77.5 0.740 3.6 (3.7) 0.298
Assessing Care of Vulnerable Elders Indicatorsd
575 108 (97.8) 20.4 79.6 3.2 (3.5)
575 118 (47.8) 30.5 69.5 0.094 3.0 (4.1) 0.747
Number of adverse eventsd
0 199 (88.0) 27.1 72.9 2.9 (3.6)
1–2 27 (12.0) 14.8 85.2 0.240 4.4 (5.0) 0.045
Mortality
Yes 30 (13.0) 20.0 80.0 4.6 (4.3)
No 200 (87.0) 26.0 74.0 0.652 2.9 (3.6) 0.017
Length of admission
Low (512 days) 113 (49.1) 31.9 68.1 2.8 (3.6)
High (512 days) 117 (50.9) 18.8 81.2 0.024 3.4 (3.9) 0.224
Discharge to institutional caree
Yes 30 (23.4) 16.7 83.8 3.50 (4.6)
No 98 (76.6) 31.6 68.4 0.163 2.15 (2.9) 0.056
a. At any assessment during hospital admission.
b. Mean score over admission.
c. Data available for n= 227 only.
d. Data available for n=226 only.
e. Data available for n=128 patients who were admitted from home and underwent a change of residence on discharge.
Table 3 Prevalence of behavioural and psychiatric symptoms of dementia on admission, and at any point during admission for
230 people in the acute hospital
Symptom present on admission (n=230) Symptom present at anytime during admission (n=230)
n % (95% CI) n % (95% CI)
Behave-AD scale
Paranoia/delusions 11 4.8 (2–8) 26 11.3 (7–15)
Hallucination 17 7.4 (4–11) 34 14.8 (10–19)
Activity disturbance 58 25.2 (20–31) 101 43.9 (37–51)
Aggressive 99 43.0 (37–49) 130 56.5 (50–63)
Sleep disturbance 39 17.0 (12–22) 97 42.2 (36–49)
Affect 37 16.1 (11–21) 77 33.5 (27–40)
Phobia/anxiety 47 20.4 (15–26) 81 35.2 (29–41)
Any symptom 142 61.7 (55–68) 172 74.8 (69–80)
Behave-AD Global Rating Scale
0, not troubling 119 51.7 (45–58) 85 37.0 (31–43)
1, mildly troubling or dangerous 45 19.6 (14–25) 46 20.0 (15–26)a
2, moderately troubling or dangerous 41 17.8 (13–23) 46 20.0 (15–26)a
3, severely troubling or intolerable 25 10.9 (7–16) 53 23.0 (18–29)a
Behave-AD, Behavioural Pathology in Alzheimer’s Disease.
a. Maximum level reached by participant during admission.
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was £15 639 (observed sample skewness, 2.69) and the median
cost £9755 (IQR £5946–£14 937). The Mann–Whitney test of
differences in costs between those with and without BPSD at
baseline was not significant (w2(1d.f.) = 0.40, P= 0.842). The
association between total cost of the admission to hospital and
mean BPSD score was not significant (average increase in cost
for each one-point increase of mean BPSD was £215.45, boot-
strap 95% CI –348.09 to 1020.37, P= 0.542).
Discussion
Behavioural and psychiatric symptoms were common in people
with dementia in the acute hospital, affecting 75% of participants
at some point during their stay. Moderately or severely troubling
BPSD occurred in 43% of participants and aggression (57%) and
activity disturbance (44%) were the most common symptoms.
Over a third of participants had symptoms of sleep disturbance,
depression, phobia or anxiety at some time during their stay.
Systematic reviews of the prevalence of BPSD in community-
dwelling older people with dementia give widely ranging results,
depending on which tools are used and the length of the
observation period.21 However, in our sample aggression and
activity disturbance were more common than in people with
dementia living in the community,22 or those living in residential
or care homes23 and higher than in large UK population samples
of people with dementia.24
The acute hospital is a challenging environment for people
with dementia and BPSD are multifactorial in origin. The
combination of an unfamiliar, disorientating and often noisy
environment with physical illness and the need for staff to
undertake physical care tasks may have increased the likelihood
that BPSD would occur.25 Studies undertaken in care homes have
demonstrated that agitation is often preceded by verbal and
physical interactions with staff26 and physical aggression is more
likely to occur when providing personal care.27
We found a possible association between BPSD (activity
disturbance and paranoia) and the risk of adverse events. These
symptoms may be more common in individuals who are
‘ambulatory’ cognitively impaired and who are at higher risk of
adverse events, such as falls.28 More severe BPSD (activity
disturbance, aggression and sleep disturbance) were associated
with mortality. This may be mediated by delirium and its
associated behavioural disturbances. Alternatively, ‘terminal
restlessness’ is a common phenomenon in people who are dying
and our behavioural rating scale may have detected these
symptoms. In clinical practice, it may be difficult to distinguish
between delirium and terminal restlessness.29,30
Dementia is known to increase the length of hospital stay in a
range of countries and types of acute care services.6 However,
our analysis did not indicate an association between BPSD at
admission and length of stay. It may be that length of stay for
people with dementia is more strongly influenced by external
factors, such as the speed at which discharge care packages can
be arranged and the availability of social care at home.31
The mean cost of admission was higher for people with BPSD
at baseline (£15 639 compared with £12 150 in those without
BPSD). However, data were highly skewed and median costs were
not different between the two groups. These figures reflect the
actual costs to the hospital of providing in-patient care and are
charges accrued to the hospital for staff contact time, prescription
medication use, hospital overheads and other running costs.
Because of variation in clinical practice and different local cost
structures, these data are less suitable for drawing wider
conclusions about the cost of providing care at a national level.
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Behavioural and psychiatric symptoms in people with dementia admitted to hospital
Length of stay has the strongest influence on costs per stay and
this may be determined by factors outside the control of the
hospital. These costs may be useful in developing future economic
evaluations of service improvements for people with dementia in
the acute hospital.
Strengths and limitations
It is possible that the participants may not be representative of the
wider population of people with dementia in acute hospitals.
However, we believe it is very likely that our results could be
generalised; we recruited from two large acute hospital trusts that
cover a population of over two million people. Previous research
conducted in this location found a dementia prevalence of
42%, which is similar to that found in other acute hospital
populations.4,5 In addition our prevalence estimates for
behavioural problems at admission are similar to those of
Goldberg et al,32 who used the Neuropsychiatric Inventory in
older people admitted to hospital. Finally the coded causes of
admission in our cohort reflect other UK statistics.33 We
attempted to reduce selection bias by screening all people who
met our inclusion criteria and carefully documenting reasons for
exclusion. Using ‘professional consultees’ enabled us to recruit
participants who may otherwise have been excluded because they
could not consent for themselves and did not have a carer or fa-
mily member to give assent for their participation.
Diagnosing dementia in the acute setting is challenging
because delirium is common in this population. However, it was
important to attempt this, as many people with dementia in the
acute hospital have not received a prior diagnosis. To reduce the
risk of misclassification of delirium as dementia we only
diagnosed new cases of dementia in the absence of delirium,
screening for delirium with the CAM version, which gives
maximum sensitivity. A recent systematic review showed the
CAM to have high specificity (96–100%) and moderate sensitivity
(77%) in distinguishing between these conditions.34 We
conducted a sensitivity analysis, excluding participants with
delirium as this may cause behavioural disturbance. This did
not markedly alter our prevalence estimates for BPSD. It is,
however, possible that incident delirium occurred between study
assessments.
Research in the acute hospital can be difficult. We reviewed
patients every 4 days, using clinical notes, and interviewed families
and ward staff in detail to ascertain whether BPSD had occurred,
but recall bias may have led to overreporting of ‘troublesome’
behaviours, for example aggression, and underreporting of
tearfulness, depression or other forms of distress. Although less
challenging for staff, these are important to people with dementia
and their carers.
We conducted multiple analyses and some of our findings may
be as a result of chance. Our study may have been underpowered
to explore associations between BPSD and other factors,
particularly for less frequent events such as mortality. It is possible
that there are residual confounding factors that we did not
consider. Factors such as admission diagnosis may have an impact
on clinical outcomes; however, reasons for admission in older
people are often complex and multifactorial. For example
pneumonia may be caused by a fall, precipitated by a urinary tract
infection; thus, defining a single cause of admission may not be
clinically relevant. In addition, agitation and behavioural
problems may themselves precipitate acute hospital admission.35
The direction of these associations is complex; adverse events
may be more common in longer hospital stays but this may be
because there is more time at risk.
Clinical implications
The results of this study demonstrate a high prevalence of
behavioural and psychiatric symptoms in people with dementia
in the acute hospital, particularly aggression and activity
disturbance. Excluding participants with delirium in a sensitivity
analysis did not markedly reduce our estimates. Despite this, many
UK acute hospitals and their staff do not have access to specialist
psychiatric advice and support or liaison services for older people.
In addition the skill-mix of staff on acute general hospital wards
may not be optimal to manage the range or severity of BPSD that
occur. Our participants were very functionally impaired; 32%
were at FAST stage 6d–e (doubly incontinent) and 14% at FAST
stage 7a–f (unable to walk, smile or hold their head up). This
finding supports recent concerns in the UK that there may be
inadequate staff numbers to undertake basic care tasks in such
dependent and vulnerable patients.36 Symptoms such as
aggression and activity disturbance are highly distressing for the
person with dementia, their families, carers, other in-patients
and acute hospital staff.
The majority of acute hospital nurses want more training and
support in managing BPSD, particularly aggression (which
occurred in over half of our participants).8 However, there have
been few evaluation studies or clinical trials on how we can best
educate staff and implement changes to improve care.37 The
severity of the behavioural and psychiatric problems found in this
study, particularly that of aggression and activity disturbance,
suggest more complex structured interventions for BPSD, similar
to those that have been shown to be successful in care homes38,39
may be required. Our results provide strong evidence for the
necessity of specialist interventions for BPSD in the acute hospital
setting, and for psychiatric liaison teams and specialists in
dementia care, to support hospital staff in managing these.
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